Traditionally structure-activity/affinity relationships (SAR) have dominated research in medicinal chemistry. However, structure-kinetics relationships (SKR) can be very informative too. In this viewpoint we explore the molecular determinants of binding kinetics and discuss challenges for future binding kinetics studies. A scheme for future kinetics-directed drug design and discovery is also proposed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/cmdc.201500310 | DOI Listing |
Publication Analysis
Top Keywords
binding kinetics
12
role target
4
target binding
4
kinetics drug
4
drug discovery
4
discovery traditionally
4
traditionally structure-activity/affinity
4
structure-activity/affinity relationships
4
relationships sar
4
sar dominated
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!